Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons

Divina S. Gryder, Michael A Rogawski

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, ∼0.5 μM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.

Original languageEnglish (US)
Pages (from-to)7069-7074
Number of pages6
JournalJournal of Neuroscience
Volume23
Issue number18
StatePublished - Aug 6 2003
Externally publishedYes

Fingerprint

Neurons
Anticonvulsants
AMPA Receptors
Kainic Acid Receptors
Ion Channels
Inhibitory Concentration 50
Gluk1 kainate receptor
Basolateral Nuclear Complex
topiramate
Pharmaceutical Preparations

Keywords

  • AMPA receptor
  • Amygdala
  • Kainate receptor
  • Patch-damp recording
  • Synaptic current
  • Topiramate

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. / Gryder, Divina S.; Rogawski, Michael A.

In: Journal of Neuroscience, Vol. 23, No. 18, 06.08.2003, p. 7069-7074.

Research output: Contribution to journalArticle

@article{671ec45a426a4e609416394e4ebb495a,
title = "Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons",
abstract = "Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, ∼0.5 μM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.",
keywords = "AMPA receptor, Amygdala, Kainate receptor, Patch-damp recording, Synaptic current, Topiramate",
author = "Gryder, {Divina S.} and Rogawski, {Michael A}",
year = "2003",
month = "8",
day = "6",
language = "English (US)",
volume = "23",
pages = "7069--7074",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "18",

}

TY - JOUR

T1 - Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons

AU - Gryder, Divina S.

AU - Rogawski, Michael A

PY - 2003/8/6

Y1 - 2003/8/6

N2 - Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, ∼0.5 μM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.

AB - Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, ∼0.5 μM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.

KW - AMPA receptor

KW - Amygdala

KW - Kainate receptor

KW - Patch-damp recording

KW - Synaptic current

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=0043127452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043127452&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 7069

EP - 7074

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 18

ER -